CACC
Credit Acceptance Corporation
CACC's fundamentals are weak: its operating margin fell 8 points to 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CACC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CACC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CACC.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CACC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.3x | $504 | — |
| Cheap | 10x | $318 | -37% |
| Fair | 14x | $417 | -17% |
| Current | 17x | $504 | — |
| Expensive | 25x | $752 | +49% |
Historical ranges are pointers, not guarantees.
CACC's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CACC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
CACC has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CACC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $53.86 | +77% |
| Q3 2026 | $30.50 | -19% |
| Q2 2026 | $45.36 | +31% |
| Q1 2026 | $40.12 | +71% |
| Q4 2025 | $36.38 | +83% |
| Q3 2025 | $37.79 | +154% |
| Q2 2025 | $34.71 | +149% |
| Q1 2025 | $23.46 | +21% |
| Q4 2024 | $19.88 | -9.6% |
CACC has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CACC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $594.6M | +2.1% |
| Q2 2026 | $587.4M | +0.6% |
| Q1 2026 | $580M | +1.6% |
| Q4 2025 | $579.9M | +2.5% |
| Q3 2025 | $582.4M | +5.8% |
| Q2 2025 | $583.8M | +8.5% |
| Q1 2025 | $571.1M | +12% |
| Q4 2024 | $565.9M | +15% |
CACC's revenue has grown year over year for 14 quarters in a row: $595M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -38 points |
| Q2 2026 | 29% | +8.5 points |
| Q1 2026 | 30% | +5.4 points |
| Q4 2025 | 27% | -6.8 points |
| Q3 2025 | 26% | +6.2 points |
| Q2 2025 | 20% | +30 points |
| Q1 2025 | 25% | +7.8 points |
| Q4 2024 | 34% | +10 points |
CACC has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CACC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $334.1M | +12% |
| Q2 2026 | $307.9M | +121% |
| Q1 2026 | $345.5M | -0.1% |
| Q4 2025 | $268.9M | -12% |
| Q3 2025 | $298.8M | -5.8% |
| Q2 2025 | $139.4M | -32% |
| Q1 2025 | $345.9M | +12% |
| Q4 2024 | $305.5M | -1.3% |
CACC has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CACC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3% | -318K shares |
| 1 year | -9.2% | -1.1M shares |
| 3 years | -20% | -2.6M shares |
| 5 years | -34% | -5.4M shares |
| Available history | -45% | -8.6M shares |
CACC has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $161.6M |
| Q2 2026 | $141.4M |
| Q1 2026 | $178.9M |
| Q4 2025 | $191.4M |
| Q3 2025 | $107.4M |
| Q2 2025 | $262.2M |
| Q1 2025 | $164.4M |
| Q4 2024 | $61.4M |
CACC spent $673M buying back its own shares over the past year, up 13% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CACC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 13.1x | High |
| Q2 2026 | 8.0x | High |
| Q1 2026 | 8.8x | High |
| Q4 2025 | 9.2x | High |
| Q3 2025 | 8.7x | High |
| Q2 2025 | 9.5x | High |
| Q1 2025 | 13.0x | High |
| Q4 2024 | 14.9x | High |
CACC's net debt is about 13 years of its operating earnings (EBITDA), up from 8.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CACC.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CACC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 26.5 | Neutral |
CACC's weekly RSI is 44 (neutral) and its Stochastic is 26 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CACC PE vs Financial Services Sector
| Metric | CACC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 13x | 27% above |
| PE % | 65 | 63 | 2 pts above |
CACC is trading at 17x earnings, a 27% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CACC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $526.9 | 4.4% below |
| 20 week MA | $571.9 | 12% below |
| 50 week MA | $526.5 | 4.4% below |
| 100 week MA | $506.2 | 0.5% below |
| 200 week MA | $496.6 | 1.4% above |
CACC has fallen below most of its moving averages, though it's still 1.4% above its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CACC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $437.2 | $329.0 | -25% |
| 2021 | $329.0 | $680.0 | +107% |
| 2022 | $680.0 | $465.2 | -32% |
| 2023 | $465.2 | $532.7 | +15% |
| 2024 | $532.7 | $469.2 | -12% |
| 2025 | $469.2 | $457.2 | -2.6% |
| 2026 YTD | $457.2 | $503.5 | +10% |
CACC has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.